En Es
Categories

Industry News

GE Healthcare implementará los primeros centros de comando hospitalarios que funcionan con IA

By Hospimedica  en español staff writers
23 Oct 2018

Imagen: El centro de comando que funciona con IA permitirá reunir todos los elementos de la experiencia hospitalaria de un paciente (Fotografía cortesía de Business Wire).GE Healthcare (Chicago, IL, EUA) colabora con proveedores de servicios hospitalarios en Europa y los EUA para implementar un centro de comando con inteligencia artificial (AI) para sincronizar de manera efectiva y eficiente todos los elementos de la experiencia hospitalaria de un paciente. El sistema que funciona por IA apoyará a los cuidadores para mejorar la seguridad de los pacientes, organizar la prestación ágil de atención y devolver a los pacientes a casa antes.

GE Healthcare es el primero de su tipo en Europa que colabora con los Bradford Teaching Hospitals NHS Foundation Trust para construir el centro de comando, en los Centros Médicos Reales de Bradford (BRI), que proporcionará una visión general, clara, instantánea y en tiempo real del hospital de 800 camas y ayudará al personal a tomar decisiones rápidas e informadas sobre cómo administrar mejor la atención a los pacientes. Hasta 20 empleados del Trust situados en el centro de comando monitorizarán un "muro de análisis" que extrae flujos de datos constantemente en tiempo real de los múltiples sistemas en el hospital. Los algoritmos avanzados ayudarán al personal a anticipar y resolver cuellos de botella en la prestación de atención antes de que ocurran, recomendando acciones para permitir una atención a los pacientes más rápida y con mayor capacidad de respuesta y una mejor asignación de recursos. Los datos se mostrarán en varias pantallas de alta definición en el centro de comando, así como en tabletas y dispositivos móviles, brindando asistencia 24-7 a los equipos médicos ocupados en todo el hospital.

En los EUA, GE Healthcare ha unido fuerzas con CHI Franciscan Health para implementar un centro de comando tipo "Control de Misión" de la NASA, lo que lo convierte en el primer sistema hospitalario en el estado de Washington, y el quinto a nivel mundial, en utilizar la tecnología más avanzada para mejorar la atención a los pacientes. El centro de control de la misión utilizará el poder de la inteligencia artificial y el análisis predictivo para optimizar la coordinación de la atención, acelerar la prestación de la atención y mejorar la experiencia de los pacientes, mientras mantiene la privacidad de ellos. El poderoso sistema funciona al considerar a cada hospital individual como parte de un sistema más grande, examinar continuamente los datos en tiempo real y usar el aprendizaje automático para recomendar acciones que pueden predecir y prevenir los riesgos, equilibrar la carga de trabajo del personal y agilizar el proceso del alta para que los pacientes puedan irse antes a la casa

Desde el centro de control de la misión, los proveedores con licencia monitorizarán y aprovecharán las aplicaciones analíticas o "fichas", para optimizar las operaciones de atención a los pacientes en cada institución y desencadenar acciones para utilizar mejor los recursos en todo el sistema. Cada ficha está diseñada cuidadosamente para resolver un problema específico, teniendo en cuenta los desafíos del mundo real, altamente matizados, de cuidadores y pacientes. Por ejemplo, una ficha ayudará a agilizar el proceso de alta hospitalaria al monitorizar a todos los pacientes programados para el alta e identificando y abordando los "puntos de pellizco" que pueden causar retrasos significativos y evitables. La clave es que los datos en tiempo real en las fichas sean predictivas y procesables.

"Los hospitales buscan aumentar, cada vez más, la eficiencia de sus operaciones para que puedan continuar brindando atención de alta calidad a medida que aumenta el volumen de pacientes. Los centros de comando ayudan a organizar la prestación de atención en toda la organización, brindando consistencia a los procesos, priorizando acciones, eliminando el desperdicio y prediciendo los puntos de presión del mañana", dijo Mark Ebbens, Líder del Centro de Comando Europeo en GE Healthcare.

"El propósito de cualquier tecnología nueva en la atención médica es permitir que los proveedores brinden una mejor atención, acercando a los médicos y enfermeras a sus pacientes", dijo Ketul J. Patel, director ejecutivo de CHI Franciscan Health. "Los poderosos análisis predictivos del control de la misión identifican problemas potenciales y permitirán que nuestros equipos de atención resuelvan problemas de manera proactiva y mejoren la atención en lugar de reaccionar cuando surjan problemas. Con la inteligencia artificial centrada en los aspectos básicos de la eficiencia operativa y la logística de atención, nuestros cuidadores pueden dedicar más tiempo para brindar la mejor atención y los mejores resultados para nuestros pacientes".

Enlace relacionado:
GE Healthcare



E-mail Print
FaceBook Twitter Google+ Linked in

GE Healthcare

GE Healthcare provides medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services. The company’s product areas include anesthesia delivery, diagnostic ECG, mammography, radiography, surgical imaging, maternal-infant care and clinical consumables.
More info

More articles about GE Healthcare

11 Jan 2023
GE HealthCare Acquires CT Navigation Innovator in France
GE HealthCare (Chicago, IL, USA) has entered into an agreement to acquire IMACTIS (Grenoble, France), an innovator in the rapidly growing field of computed tomography (CT) interventional guidance across an array of care areas.
Read More
05 Dec 2022
New Collaboration to Bring AR to Medical Imaging for Interventional Space
GE Healthcare (Chicago, IL, USA) and MediView XR, Inc. (Cleveland, OH, USA) have entered into a collaboration to integrate medical imaging into mixed reality solutions through the development of the OmnifyXR Interventional Suite System.
Read More
13 Oct 2022
GE Files Registration Statement for Planned Spin-Off of GE HealthCare
GE (Boston, MA, USA) has announced the filing of the Form 10 registration statement with the U.S. Securities and Exchange Commission (SEC) for the planned spin-off of its Healthcare division, to be called GE HealthCare.
Read More
20 Jul 2022
GE's Healthcare Business to Be Named GE HealthCare
GE (Boston, MA, USA) has announced that GE HealthCare will be the name of its healthcare business following its planned separation into three industry-leading, global, investment-grade public companies.
Read More
29 Apr 2022
GE Healthcare and Medtronic Collaborate to Improve Product Access for ASCs and OBLs
GE Healthcare (Chicago, IL, USA) and Medtronic (Doral, FL, USA) have entered into a collaboration focused on the unique needs and demand for care at Ambulatory Surgery Centers (ASCs) and Office Based Labs (OBLs) that will allow customers to access extensive product portfolios, financial solutions, and exceptional service.
Read More
23 Dec 2021
GE Healthcare Completes Acquisition of BK Medical to Expand Its Ultrasound Business
GE Healthcare (Chicago, IL, USA) has completed its previously announced acquisition of BK Medical (Peabody, MA, USA; www.bkmedical.com) in a deal that would expand its ultrasound business from diagnostics into surgical and therapeutic interventions.
Read More
13 Nov 2021
GE Healthcare to be Spun Off in 2023 to Create Pure-Play Company at Center of Precision Health
General Electric (GE; Boston, MA, USA) plans to pursue a tax-free spin-off of GE Healthcare, creating a pure-play company at the center of precision health in early 2023.
Read More
30 Sep 2021
GE Healthcare Acquires BK Medical to Expand Ultrasound Portfolio into Surgical Visualization
GE Healthcare (Chicago, IL, USA) has entered into an agreement to acquire BK Medical (Peabody, MA, USA) in a deal that is expected to create value by further strengthening BK, including through significant synergies with the benefit of GE’s technology and commercial scale.
Read More

Additional news

25 Jan 2023
Global Diagnostic Imaging Services Market Driven by Rising Prevalence of Chronic Diseases
The global diagnostic imaging services market was valued at USD 40.80 billion in 2021 and is expected to register a CAGR of 5.8% during the forecast period 2022-2030 to reach USD 67.94 billion in 2030, driven by the rising prevalence of chronic diseases, increasing elderly population, and rapid technological advancements in the healthcare diagnostic industry.
Read More
25 Jan 2023
Global Endoscopy Equipment Market Driven by Growing Hospital Investment in Advanced Instruments
The global endoscopy equipment market is projected to register a CAGR of 7% from USD 28.9 billion in 2022 to USD 40.6 billion by 2027, driven by increasing demand for endoscopy to diagnose and treat target diseases, rising investments, funds, and grants by governments and other organizations across the world, and growing focus by hospitals on investing in technologically-advanced endoscopy instruments and expanding endoscopy units.
Read More
25 Jan 2023
Point-of-Care Glucose Testing Market to Reach Almost USD 6 Billion by 2032
The global point-of-care (POC) glucose testing market is projected to register a CAGR of 4.3% during the forecast period from 2022 to 2032 to reach USD 5.8 billion by 2032, driven by a rise in the geriatric population, speed & precision of POC screening, increased adoption of electronic medical information, and the higher risk of COVID-19-related mortality associated with diabetes.
Read More
24 Jan 2023
Carolina Liquid Chemistries and Diazyme Enter Into Partnership
Carolina Liquid Chemistries, Corp. (CLC, Greensboro, NC, USA) and Diazyme Laboratories, Inc. (San Diego, CA, USA) have entered into a partnership to expand the test menu on the Diazyme DZ-Lite c270 benchtop clinical chemistry analyzer, allowing it to run both special and routine chemistries.
Read More
23 Jan 2023
Mindray Defibrillators Amongst the World’s First to Receive MDR Clearance
Mindray has received the CE marking for its defibrillation product family under the European Union's newest Medical Device Regulation (MDR). With the new rule tightening the controls for defibrillation devices, Mindray has become among the first manufacturers in the world to earn MDR accreditation for product quality and effectiveness.
Read More
23 Jan 2023
Siemens Launches Centre of Excellence for Immunoassay Instrument R&D in Ireland
Siemens Healthineers has launched a Center of Excellence for Immunoassay Instrument Research and Development (R&D) in Swords, Ireland. The new center will focus on unlocking breakthrough innovations in laboratory instruments used to detect infectious diseases, cancer and blood disorders.
Read More
20 Jan 2023
Global Intensive Care Unit (ICU) Equipment Market Driven By Increasing Neurological Diseases
The global intensive care unit (ICU) equipment market was valued at USD 6.6 billion in 2021 and is estimated to register a CAGR of 3.9% from 2022 to 2031 to reach USD 9.6 billion by 2031, driven primarily by a rise in the prevalence of neurological diseases.
Read More
20 Jan 2023
Bayer Acquires Imaging AI Platform Provider in the UK
Bayer (Leverkusen, Germany) has acquired Blackford Analysis Ltd. (Edinburgh, UK), a global strategic imaging AI platform and solutions provider. The acquisition is part of Bayer's strategy to drive innovation in radiology, including the development and adoption of AI within the clinical workflow, with the goal to ultimately improve patient care and advance the company’s position in digital medical imaging.
Read More
16 Jan 2023
Medlab Middle East Sees 100% Increase in Exhibitor Numbers
Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress, has sold out its exhibitor space ahead of the show, which returns to the Dubai World Trade Centre from February 6 to 9, 2023.
Read More
Copyright © 2000-2023 TradeMed.com. All rights reserved. | Terms And Conditions